Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator "FASTFlo tPA"

Completed

Phase 1 Results N/A

Main Contacts

Name Phone E-mail
FASTFlo Steering Committee Study Director

Other Locations

Name City State Country Status
Trillium Health Centre Mississauga Ontario Canada Unknown_status_icon
University of Alberta Edmonton Alberta Canada Unknown_status_icon
University of Western Ontario London Ontario Canada Unknown_status_icon
University of Erlangen Erlangen Germany Unknown_status_icon